The CA-125 Test is a key component of the Ovarian Cancer Markers package. It measures the levels of CA-125 protein in the blood, which is often elevated in women with ovarian cancer.

This test plays a crucial role in the early detection and monitoring of ovarian cancer. It is a simple blood test that provides valuable information about the presence and progression of the disease.

Elevated CA-125 levels may indicate the need for further diagnostic tests or treatment. Regular monitoring of CA-125 levels can help track the effectiveness of treatment and detect any recurrence of the disease.

The CA-125 Test is an essential tool in the fight against ovarian cancer.

The Carcino Embryonic Antigen-CEA test is another important test included in the Ovarian Cancer Markers package.

CEA is a protein that may be elevated in certain types of cancer, including ovarian cancer.

This test measures the levels of CEA in the blood and helps in the detection and monitoring of ovarian cancer.

Elevated CEA levels can indicate the presence of cancer cells or the progression of the disease.

Regular monitoring of CEA levels can provide valuable information about the effectiveness of treatment and the risk of recurrence.

The Carcino Embryonic Antigen-CEA test is a valuable tool for assessing ovarian cancer markers.

The CA-72.4 Test is an integral part of the Ovarian Cancer Markers package.

CA-72.4 is a protein marker that is frequently associated with ovarian cancer.

This test measures the levels of CA-72.4 protein in the blood and aids in the detection and monitoring of ovarian cancer.

Elevated CA-72.4 levels can be indicative of the presence of cancer cells or the progression of the disease.

Regular monitoring of CA-72.4 levels is essential to assess the effectiveness of treatment and to identify any recurrence of the disease.

The CA-72.4 Test provides valuable insights into ovarian cancer markers.

The ROMA Index with HE4 Test is a unique component of the Ovarian Cancer Markers package.

This test combines the results of the HE4 Test and CA-125 Test to provide a more accurate assessment of the risk of ovarian cancer.

HE4 is a protein marker that is often elevated in women with ovarian cancer.

The ROMA Index calculates the risk of ovarian cancer based on the levels of HE4 and CA-125 proteins in the blood.

This test helps in the early detection and monitoring of ovarian cancer.

By combining multiple markers, the ROMA Index with HE4 Test enhances the accuracy of ovarian cancer marker evaluation, enabling better diagnosis and treatment decisions.

The Ovarian Cancer Markers package targets various diseases and conditions that are associated with elevated levels of CA-125, CEA, CA-72.4, ROMA Index with HE4, and Cancer Marker CA-19 9.

These tests help in the diagnosis of ovarian cancer, as well as other gynecological cancers, such as endometrial cancer and fallopian tube cancer.

Additionally, they can be useful in monitoring the progression of the disease and assessing the effectiveness of treatment.

By analyzing these specific markers, the package provides valuable insights into the presence or absence of these diseases, enabling healthcare professionals to make informed decisions regarding further investigation and management.

The Ovarian Cancer Markers package includes the following:

1. CA-125: Elevated levels of CA-125 are associated with ovarian cancer and can aid in its diagnosis.
2. CEA: Elevated levels of CEA can indicate the presence of various cancers, including ovarian cancer.
3. CA-72.4: Increased levels of CA-72.4 are often observed in ovarian cancer patients.
4. ROMA Index with HE4: The ROMA Index, combined with HE4 levels, can help in the assessment of ovarian cancer risk.
5. Cancer Marker CA-19 9: Elevated levels of CA-19 9 are associated with multiple types of cancer, including ovarian cancer.

The Ovarian Cancer Markers package includes a comprehensive set of tests designed to evaluate the levels of CA-125, CEA, CA-72.4, ROMA Index with HE4, and Cancer Marker CA-19 9 in the blood.

The CA-125 test measures the amount of CA-125 protein, which is often elevated in ovarian cancer.

The CEA test detects the presence of carcinoembryonic antigen, which can be indicative of various types of cancer, including ovarian cancer.

The CA-72.4 test assesses the levels of CA-72.4 protein, which is associated with ovarian and gastrointestinal cancers.

The ROMA Index with HE4 test combines the measurement of HE4 protein and CA-125 levels to improve the accuracy of ovarian cancer detection.

The Cancer Marker CA-19 9 test helps in the diagnosis and monitoring of gastrointestinal and pancreatic cancers.

Together, these tests provide a comprehensive evaluation of potential cancer markers, aiding in early detection and diagnosis.

If you are experiencing persistent abdominal pain, bloating, changes in bowel habits, frequent urination, pelvic discomfort, or unexplained weight loss, it is recommended to consider the Ovarian Cancer Markers package.

These symptoms, although non-specific, can be associated with ovarian cancer and other gynecological malignancies. It is essential to remember that these symptoms can also be caused by various other conditions. However, by undergoing this package of tests, you can assess the presence of specific markers associated with ovarian cancer and other related diseases, providing valuable information to your healthcare provider for further investigation and appropriate management.

At Pathofast Lab, we prioritize your safety and well-being.

Our lab is equipped with state-of-the-art facilities and follows strict hygiene protocols to ensure a safe and clean environment.

We maintain high standards of cleanliness to minimize the risk of contamination and provide you with accurate and reliable test results.

Our dedicated team of professionals ensures that all equipment and surfaces are regularly sanitized.

Trust Pathofast Lab for a safe and hygienic testing experience.

We understand the importance of convenience when it comes to getting tested. That's why Pathofast Lab offers a unique service of free home visits for sample collection.

Our trained professionals will visit your home at your preferred time to collect the necessary samples for testing. This eliminates the need for you to travel to the lab, saving you time and effort.

Enjoy the convenience of getting tested from the comfort of your own home with Pathofast Lab.

At Pathofast Lab, we believe in empowering our patients with knowledge. That's why we utilize advanced AI technology to provide detailed explanations of your lab reports.

Our intelligent system analyzes your test results and generates easy-to-understand explanations, highlighting important findings and potential health implications. With our AI-powered explanations, you can make informed decisions about your health and take appropriate actions if necessary.

Trust Pathofast Lab for accurate test results and comprehensive insights.

If you have a family history of ovarian cancer, the Ovarian Cancer Markers Panel is highly recommended. This panel can help identify any potential genetic predispositions or markers associated with the disease. By detecting these markers early on, you can take necessary precautions and make informed decisions about your health.

The Ovarian Cancer Markers Panel is especially beneficial for individuals with a first-degree relative (parent, sibling, or child) who has been diagnosed with ovarian cancer. It can provide valuable insights into your risk profile and help you and your healthcare provider develop a personalized screening and prevention plan.

Experiencing persistent symptoms such as abdominal pain, bloating, frequent urination, or difficulty eating? The Ovarian Cancer Markers Panel can help evaluate these symptoms and provide a comprehensive assessment of your ovarian health.

If you have been experiencing any of these symptoms for an extended period, it is crucial to get them evaluated by opting for the Ovarian Cancer Markers Panel. The panel's tests, including:

1. CA-125 Test
2. Carcino Embryonic Antigen-CEA
3. CA-72.4 Test
4. ROMA Index with HE4 Test
5. Cancer Marker CA -19 9

These tests can help identify any potential ovarian cancer markers and provide early detection and intervention.

If you have previously been diagnosed with ovarian cancer and have completed treatment, the Ovarian Cancer Markers Panel can play a crucial role in monitoring your ongoing health. This panel aims to assess the effectiveness of your treatment and detect any potential recurrence or progression of ovarian cancer.

By opting for the Ovarian Cancer Markers Panel, you can regularly monitor your ovarian health and detect any changes at an early stage. This can help you and your healthcare provider make informed decisions regarding further treatment and management options.